Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(17%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_1
1
8%
Ph phase_4
3
25%
Ph phase_3
2
17%
Ph not_applicable
6
50%

Phase Distribution

1

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
3(25.0%)
N/ANon-phased studies
6(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting2
Enrolling by invitation1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 32 (16.7%)
Phase 43 (25.0%)
N/A6 (50.0%)

Trials by Status

enrolling_by_invitation18%
withdrawn18%
unknown217%
recruiting217%
completed650%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12